Hijacking of inflammasome responses by the complement system during Pseudomonas aeruginosa – Aspergillus fumigatus sur-infection
Preprint
Abstract
Patients with cystic fibrosis (pwCF) are highly susceptible to chronic pulmonary infections due to mutations in the CFTR gene. From early childhood, pwCF experience repeated lung infections and often develop chronic bacterial and/or fungal colonization. Among the most clinically relevant pathogens, Pseudomonas aeruginosa and Aspergillus fumigatus frequently co-infect and are associated with worse outcomes, including excessive IL-1β-driven inflammation and accelerated lung function decline. Here we investigated the mechanisms underlying inflammasome overactivation during super-infection. We found that inflammasome hyperactivation occurred across macrophage populations, was independent of exogenous priming, and required live co-infection with both pathogens. P. aeruginosa and A. fumigatus cooperatively activated the NLRP3 inflammasome, and this response required both caspase-1 and caspase-8. Unexpectedly, gasdermin D was dispensable for IL-1β release. Bacterial flagellin, type IV pili and the type III secretion system, as well as the fungal polysaccharide galactosaminogalactan (GAG), were each required for overactivation. Mechanistically, P. aeruginosa activated the MyD88–TLR pathway, enhancing macrophage responses and promoting ITGAM (CD11b) expression. Under fungal super-infection, macrophages secreted complement component C3, which may bound fungal surface and engaged the complement receptor C3R (CD11b/CD18). Downstream SYK and ERK signaling amplified inflammasome activation and IL-1β release. Single-cell transcriptomic analysis of pwCF broncho-alveolar lavage and lung samples supported coordinated upregulation of complement and inflammasome pathways during bacterial-fungal infection. Together, these findings identify a complement–inflammasome signaling axis that drives pathological inflammation during bacterial-fungal co-infection in airways of pwCF and may represent a therapeutic target.Keywords
Funding Information
- Vaincre la mucoviscidose (RF20220503069)
- Vaincre la mucoviscidose (RF20230503265)
- Vaincre la mucoviscidose (RF20240503504)
- Agence Nationale de la Recherche (ANR-23-CE15-0013-03)
- Agence Nationale de la Recherche (ANR-24-CE15-2995-03)
- Agence Nationale de la Recherche (ANR-25-CE15-1868-01)
This publication has 41 references indexed in Scilit:
- Aspergillus fumigatus and Mycobacterium tuberculosis synergistically induce TNF and IL-1β via different pathways in human peripheral blood mononuclear cellsCytokine, 2025
- Evidence for altered immune-structural cell crosstalk in cystic fibrosis revealed by single cell transcriptomicsJournal of Cystic Fibrosis, 2025
- Clinical characteristics of Pseudomonas and Aspergillus co-infected cystic fibrosis patients: A UK registry studyJournal of Cystic Fibrosis, 2022
- The NLRP3 inflammasome drives inflammation in ischemia/reperfusion injury after transient middle cerebral artery occlusion in miceBrain, Behavior, and Immunity, 2021
- Emerging Activators and Regulators of Inflammasomes and PyroptosisTrends in Immunology, 2019
- Near-optimal probabilistic RNA-seq quantificationNature Biotechnology, 2016
- Concerted Activation of the AIM2 and NLRP3 Inflammasomes Orchestrates Host Protection against Aspergillus InfectionCell Host & Microbe, 2015
- Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1β via a noncanonical caspase-8 inflammasomeNature Immunology, 2012
- Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteriaNature Immunology, 2010
- Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-bNature Immunology, 2010